-
MA Deadline Extensions for 21-22: CMS Policy Update and Strategy Guidance
Earlier this year, we discussed the final call letter from CMS detailing the Medicare Advantage (MA) deadline extensions for PY 2020 (i.e. 2019 dates of service) to account for COVID-19 related disruptions. We suspected, but had no confirmation at the time, that this would continue going forward. While CMS hasn’t made any public announcements, we […]
-
Medical Loss Ratio and COVID-19: Investment, Risk, and Looking through 2022
For payors, Medical Loss Ratio is down to a point of short-term crisis and long-term complication this year and next. However, there is a solution: payer investment in pre-encounter programs that drive quality and care.
-
True Disruption: Three Ways the Pandemic has Shaped Risk Adjustment Technology
Health Fidelity CEO Steve Whitehurst shares how our company has worked to recognize the long-term impacts of this pandemic on healthcare, and how we’ve sought to support our current and future customers experience with our risk adjustment technology going forward.
-
Flattening the Other Curve: Using Risk Adjustment to Manage Rebounding Patient Volumes
As care patterns continue to shift, and we see new utilization patterns, the stability of capitation and the revenue insulation provided by thorough, effective risk adjustment are key to thriving during uncertain times.
-
Remote Operations: Adapting to a Crisis Does Not Mean Idle
Health Fidelity CEO, Steve Whitehurst, shares a couple of examples that illustrate how our leadership is thinking strategically about supporting our clients beyond the COVID-19 crisis to bolster their success.
-
Six Emergent Best Practices in Telehealth Risk Adjustment Coding
Telemedicine is accelerating, in both adoption and refinement; review the emerging best practices for actionable insights to ensure effective submission and mitigate audit risk.
-
Remote Operations: Thriving as a Distributed Workplace During and After Pandemic Conditions
HF CEO discusses remote agile development in the midst of a pandemic, from the need to assess the market and determine how to respond, how the market may recover, and how we might need to retool to address a different world.
-
Accelerating Recovery in Reimbursement for Value-based Care Post COVID-19
Implementing a post-encounter coding review is an effective way to ensure complete and accurate capture of all 2020 risk adjustable conditions - without burdening clinical teams - while informing care and stabilizing revenue. Finding and closing these gaps today, with fee-for-service revenues having bottomed out and many provider organizations in a precarious financial position, is especially critical.
-
Remote Operations: Supporting Staff and Clients Before, During, and After Pandemic Conditions
While some states are already discussing re-opening processes, decentralized businesses are likely to become much more common going forward, especially over the next year or so as we continue to work together to address COVID-19 and its ancillary impacts. Health Fidelity has been very fortunate in that a large portion of our staff already worked […]
-
The Future of Value-Based Care Post COVID-19
Robin Lloyd, HF Chief Commercial Officer, envisions the longer-term impact on healthcare delivery, policy, and technology following the coronavirus pandemic.
-
Risk Adjustment and Telehealth Policy under COVID-19
Health Fidelity offers conclusions on the flurry of CDC and CMS telehealth policy updates around coding and risk adjustment practices under COVID-19
-
Identifying Risk Adjustable Telehealth Patients in a Post COVID-19 World
Health Fidelity looked for a way to harness our expertise to assist our payer and provider partners provide continuity of care to their chronically ill patients. We decided to help providers identify and prioritize those patients who would be best served by telemedicine via a simple and quick suspecting report.
